In the nanomedicine field, there is a need to widen the availability of nanovectors to compensate for the increasingly reported side effects of poly(ethene glycol). Nanovectors enabling cross-linking can further optimize drug delivery. Cross-linkable polyoxazolines are therefore relevant candidates...
Bibliographische Detailangaben
Veröffentlicht in: | Langmuir : the ACS journal of surfaces and colloids. - 1992. - 38(2022), 51 vom: 27. Dez., Seite 16144-16155
|
1. Verfasser: |
Belkhir, Kedafi
(VerfasserIn) |
Weitere Verfasser: |
Cerlati, Orélia,
Heaugwane, Diana,
Tosi, Alice,
Benkhaled, Belkacem Tarek,
Brient, Pierre-Louis,
Chatard, Camille,
Graillot, Alain,
Catrouillet, Sylvain,
Balor, Stéphanie,
Goudounèche, Dominique,
Payré, Bruno,
Laborie, Pascale,
Lim, Jia-Hui,
Putaux, Jean-Luc,
Vicendo, Patricia,
Gibot, Laure,
Lonetti, Barbara,
Mingotaud, Anne-Françoise,
Lapinte, Vincent |
Format: | Online-Aufsatz
|
Sprache: | English |
Veröffentlicht: |
2022
|
Zugriff auf das übergeordnete Werk: | Langmuir : the ACS journal of surfaces and colloids
|
Schlagworte: | Journal Article
Research Support, Non-U.S. Gov't
poly(2-methyl-2-oxazoline)
Polymers
Polyamines
Micelles |